Home
Storia in 2 fonti
Create Medicines raises $122M to bolster in vivo CAR-T therapies
The fresh funds will support the biotech's pipeline of RNA-based CAR-T cell therapies for cancer and autoimmune conditions.
- ·
biopharmadive.com
Create Medicines raises $122M to bolster in vivo CAR-T therapies
The fresh funds will support the biotech's pipeline of RNA-based CAR-T cell therapies for cancer and autoimmune conditions.
- ·
statnews.com
CREATE Medicines, a biotech company developing CAR-T therapies, raises $122 million
CREATE Medicines has a new name, an expanded pipeline, and now fresh funding to propel the company’s first CAR-T candidates through human trials.